ACADIA Pharmaceuticals In... (ACAD)
NASDAQ: ACAD
· Real-Time Price · USD
17.17
-0.03 (-0.17%)
At close: May 14, 2025, 3:59 PM
16.69
-2.80%
Pre-market: May 15, 2025, 04:11 AM EDT
ACADIA Pharmaceuticals Revenue Breakdown
| Period Ending | Dec 31, 2018 |
|---|---|
| Product Revenue | 223.81M |
| Product Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 126.37M | 130.08M | 133.29M | 117.06M | 107.99M | 111.47M | 97.89M | 95.97M | 101.23M | 104.4M | 78.11M | 89.9M | 96.68M | 105.77M | 81.67M | 96.79M | 111.66M | 120.75M | 81.59M | 84.34M | 101.97M | 91.87M | 72.7M | 67.98M | 93.09M | 74.27M | 61.09M | 69.47M | 60.93M | 66.69M | 62.26M | 61.52M | 65.75M | 57.66M | 50.53M | 50.77M | 27.49M | 25.12M | 20.31M | 21.12M | 24.26M |
| Selling, General, and Administrative Revenue Growth | -2.85% | -2.41% | +13.87% | +8.40% | -3.12% | +13.87% | +2.00% | -5.20% | -3.03% | +33.66% | -13.12% | -7.01% | -8.60% | +29.52% | -15.62% | -13.32% | -7.53% | +47.99% | -3.26% | -17.29% | +11.00% | +26.38% | +6.94% | -26.97% | +25.34% | +21.58% | -12.07% | +14.03% | -8.64% | +7.12% | +1.19% | -6.42% | +14.02% | +14.11% | -0.46% | +84.67% | +9.46% | +23.68% | -3.84% | -12.95% | n/a |
| Research and Development Revenue | 78.27M | 100.73M | 66.61M | 76.23M | 59.68M | 66.74M | 156.96M | 58.77M | 69.14M | 75.74M | 81.34M | 75.65M | 128.85M | 67.08M | 58.56M | 56.94M | 56.97M | 62.12M | 120.08M | 64.3M | 72.64M | 57.52M | 62.62M | 67.32M | 52.92M | 48.18M | 53.11M | 46.59M | 39.28M | 43.18M | 36.42M | 34.18M | 35.41M | 30.22M | 25.81M | 20.48M | 22.77M | 20.47M | 18.73M | 18.38M | 16.3M |
| Research and Development Revenue Growth | -22.30% | +51.23% | -12.63% | +27.74% | -10.58% | -57.48% | +167.08% | -15.00% | -8.71% | -6.88% | +7.52% | -41.29% | +92.08% | +14.55% | +2.86% | -0.07% | -8.28% | -48.27% | +86.77% | -11.48% | +26.28% | -8.15% | -6.98% | +27.20% | +9.84% | -9.28% | +13.99% | +18.63% | -9.04% | +18.56% | +6.56% | -3.47% | +17.18% | +17.07% | +26.05% | -10.09% | +11.28% | +9.27% | +1.90% | +12.79% | n/a |